Efficacy and safety of ruxolitinib plus extracorporeal photopheresis in acute and chronic graft versus host disease: A single center experience. Annals of Medical Research, [S. l.], v. 28, n. 11, p. 2065–2070, 2021. Disponível em: http://www.annalsmedres.org/index.php/aomr/article/view/3977. Acesso em: 9 may. 2025.